These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 18923436

  • 1. Miscreant myeloproliferative disorder stem cells.
    Jamieson CH, Barroga CF, Vainchenker WP.
    Leukemia; 2008 Nov; 22(11):2011-9. PubMed ID: 18923436
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
    Kometani K, Aoki M, Kawamata S, Shinozuka Y, Era T, Taniwaki M, Hattori M, Minato N.
    Cancer Res; 2006 Oct 15; 66(20):9967-76. PubMed ID: 17047059
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Kinase drug discovery approaches in chronic myeloproliferative disorders.
    Kumar C, Purandare AV, Lee FY, Lorenzi MV.
    Oncogene; 2009 Jun 18; 28(24):2305-13. PubMed ID: 19421140
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.
    Huntly BJ, Shigematsu H, Deguchi K, Lee BH, Mizuno S, Duclos N, Rowan R, Amaral S, Curley D, Williams IR, Akashi K, Gilliland DG.
    Cancer Cell; 2004 Dec 18; 6(6):587-96. PubMed ID: 15607963
    [Abstract] [Full Text] [Related]

  • 8. BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia.
    Chu S, Li L, Singh H, Bhatia R.
    Cancer Res; 2007 Jul 15; 67(14):7045-53. PubMed ID: 17638918
    [Abstract] [Full Text] [Related]

  • 9. Chronic versus acute myelogenous leukemia: a question of self-renewal.
    Jamieson CH, Weissman IL, Passegué E.
    Cancer Cell; 2004 Dec 15; 6(6):531-3. PubMed ID: 15607956
    [Abstract] [Full Text] [Related]

  • 10. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.
    Cuenco GM, Ren R.
    Oncogene; 2001 Dec 13; 20(57):8236-48. PubMed ID: 11781838
    [Abstract] [Full Text] [Related]

  • 11. Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment.
    Clarkson B, Strife A.
    Leukemia; 1993 Nov 13; 7(11):1683-721. PubMed ID: 8231240
    [Abstract] [Full Text] [Related]

  • 12. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K, Pinto do O P, Hägglund AC, Wahlin A, Carlsson L.
    Haematologica; 2003 Dec 13; 88(12):1336-47. PubMed ID: 14687986
    [Abstract] [Full Text] [Related]

  • 13. Infrequent hypermethylation of WIF-1 promoter in BCR/ABL-negative myeloproliferative disorders.
    Suzuki R, Onizuka M, Kojima M, Shimada M, Tsuboi K, Ogawa Y, Kawada H, Ando K.
    Tokai J Exp Clin Med; 2007 Dec 20; 32(4):131-5. PubMed ID: 21318952
    [Abstract] [Full Text] [Related]

  • 14. Hemangioblastic characteristics of cancer stem cells in chronic myeloid leukemia.
    Xishan Z, Xu Z, Lawei Y, Gang L.
    Clin Lab; 2012 Dec 20; 58(7-8):607-13. PubMed ID: 22997961
    [Abstract] [Full Text] [Related]

  • 15. Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies.
    Clarkson B, Strife A, Wisniewski D, Lambek CL, Liu C.
    Leukemia; 2003 Jul 20; 17(7):1211-62. PubMed ID: 12835715
    [Abstract] [Full Text] [Related]

  • 16. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells.
    Passegué E, Wagner EF, Weissman IL.
    Cell; 2004 Oct 29; 119(3):431-43. PubMed ID: 15507213
    [Abstract] [Full Text] [Related]

  • 17. The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence.
    Bruns I, Czibere A, Fischer JC, Roels F, Cadeddu RP, Buest S, Bruennert D, Huenerlituerkoglu AN, Stoecklein NH, Singh R, Zerbini LF, Jäger M, Kobbe G, Gattermann N, Kronenwett R, Brors B, Haas R.
    Leukemia; 2009 May 29; 23(5):892-9. PubMed ID: 19158832
    [Abstract] [Full Text] [Related]

  • 18. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV, Gerasimova LP, Sarkisian GP, Borovkova TV, Dukhovenskaia EA, Manakova TE, Naĭdenova NM, Timofeev AM, Grineva NI.
    Tsitologiia; 2007 May 29; 49(10):889-900. PubMed ID: 18074781
    [Abstract] [Full Text] [Related]

  • 19. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
    Schulze E, Krahl R, Thalmeier K, Helbig W.
    Exp Hematol; 1995 Dec 29; 23(14):1649-54. PubMed ID: 8542960
    [Abstract] [Full Text] [Related]

  • 20. The fundamental prevalence of chronic myeloid leukemia-generating clonogenic cells in the light of the neutrality theory of evolution.
    Jankovic GM, Pavlovic M, Vukomanovic DJ, Colovic MD, Lazarevic V.
    Blood Cells Mol Dis; 2001 Dec 29; 27(5):913-7. PubMed ID: 11783955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.